Measurement of Ocular Blood Flow and Retinal Oxygen Extraction in Diabetic Patients
Recruiting now · Not applicable
Conditions studied: Diabetes Mellitus
In brief
The prevalence of diabetes is increasing, with type 2 diabetes mellitus comprising over 90% of cases. Diabetes mellitus complications, including diabetic retinopathy (DR), impose significant health burdens. GLP-1 receptor agonists (GLP-1RAs) and dual GIP/GLP-1 receptor agonists show promise in improving cardiovascular and kidney outcomes, but their effects on retinal microvasculature and neuroprotection remain unclear. This study investigates the impact of GLP-1RAs (semaglutide, liraglutide) and GIP/GLP-1-dual agonists (tirzepatide) on ocular blood flow and retinal function in DM patients.
Key facts
- Study ID
- NCT07536516
- Run by
- Medical University of Vienna
- People needed
- 20
- Starts
- 2025-11-28
- Expected to finish
- 2026-06-01
- Last updated by the study team
- 2026-04-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Men and women aged ≥ 18 years
- Signed informed consent
- Previously diagnosed diabetes mellitus
- Normal ophthalmic findings except diabetic retinopathy, unless the investigator considers an abnormality to be clinically irrelevant
- Planned initiation of therapy with GLP-1 receptor agonist (Semaglutide, Ozempic®; Liraglutide, Victoza®) or GIP/GLP-1 receptor agonist (Tirzepatide, Mounjaro®) by a diabetes specialist
You may not qualify if…
- Participation in a clinical trial in the 3 weeks preceding the screening visit
- Symptoms of a clinically relevant illness in the 3 weeks before the first study day
- Presence or history of a severe medical condition, except diabetes, as judged by the clinical investigator
- Abuse of alcoholic beverages
- Blood donation during the previous three weeks
- Presence of any abnormalities preventing reliable measurements in the study eye as judged by the investigator
- Previous laser photocoagulation treatment in the study eye
- Best corrected visual acuity < 0.4 Snellen
- Women of childbearing potential (neither menopausal, nor hysterectomized, nor sterilized) not using effective contraception
- Pregnancy, planned pregnancy or lactation
Where it is running
- Medical University Vienna — Vienna, State of Vienna, Austria (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.